Chronic Total Occlusion

"Chronic total occlusions bring their own challenges. They come in a big spectrum of lesions. have to have good technology and solutions to overcome those specific challenges.6"

Be the Next CTO Expert

Push the boundaries of innovation. Leverage the hybrid approach to treat chronic total occlusions safely – with maximum efficiency and success. Boston Scientific can help you build your CTO program with specialized training, unique tools, and ongoing case support. Partner with us to bridge coronary CTOs.

Common Occurrence

CTOs are very common, occurring in as many as 30% of patients with significant coronary artery disease.1,2


Patients with CTOs are most often treated with medical therapy or coronary artery bypass graft (CABG) rather than PCI.


Recent meta-analyses and large registries have shown that successful CTO PCI is associated with symptom relief, a reduction in long-term mortality, and a lower need for coronary artery bypass graft (CABG) surgery.3,4,5